vimarsana.com
Home
Live Updates
Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) : vimarsana.com
Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HAMILTON, ON and BOSTON, June 7, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision... | June 7, 2023
Related Keywords
Boston ,
Massachusetts ,
United States ,
Amanda Cray ,
Investor Relations Corporate Communications ,
Fusion Pharmaceuticals ,
Niowave Inc ,
Company Board Of Directors ,
Astrazeneca ,
Nasdaq ,
Prnewswire Fusion Pharmaceuticals Inc ,
Nasdaq Listing Rule ,
Response Inhibitors ,
Senior Director ,
Investor Relations ,
Corporate Communications ,
Fusn Phar Stock Exchange ,
News ,
Information ,
Press Release ,
N ,
End ,
Pune ,
023 ,
Fusion ,
Pharmaceuticals ,
Ncology ,
Company ,
Ocused ,
Developing ,
Radiopharmaceuticals ,
S Fusn Ca36118a1003 ,
vimarsana.com © 2020. All Rights Reserved.